NIH AI Restriction
NIH policy NOT-OD-25-132 prohibits the use of AI-generated text in grant applications that is not substantially modified by the applicant. All AI-drafted sections must be thoroughly rewritten in your own words before submission.
View full policyExploratory Clinical Trial Grants in Arthritis and Musculoskeletal and Skin Diseases
About This Grant
The National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) intends to publish a Notice of Funding Opportunity (NOFO) to solicit applications for Exploratory Clinical Trials Grants Program in the mission areas of NIAMS. The goal of the NIAMS clinical trial program is to support research leading to the prevention or reduction of symptoms and improve outcomes and function in patients with rheumatic, musculoskeletal, or skin conditions or diseases. The purpose of the Exploratory Clinical Trials Grants Program is to foster clinical trials that will lead to clinically meaningful improvements in prevention, diagnosis, or treatment of these conditions or diseases.
This Exploratory Clinical Trials Grants Program is designed to facilitate the execution of short-term, interventional studies. The Program is intended to support a range of exploratory studies, from proof-of-concept/first in human to Phase I and Phase II clinical trials. Such studies must meet the NIH definition of a clinical trial and be feasible within the time and budget constraints of this NOFO. A high priority is the use of such studies to stimulate the translation of promising research developments from laboratory, preclinical, and early human testing into clinical practice.
Examples of research areas of interest include, but are not limited to:
• Conducting early-stage clinical trials, such as but not limited to; first in human, dose-finding or escalation/tolerability/safety/efficacy studies with drugs, biologics, devices, behavioral interventions, and/or physical therapy for treatment of arthritis, musculoskeletal, or skin conditions or diseases. • Clinical trials to provide data required to support a future, more robust clinical trial whose aim is to help establish the safety and efficacy or effectiveness of an intervention. • Clinical trials in rare diseases where the number of potential study participants is limited. • Clinical trials to determine the predictive value of a potential biomarker.
Grant Summary
Exploratory Clinical Trial Grants in Arthritis and Musculoskeletal and Skin Diseases is a National Institutes of Health grant providing $300K to $600K for small business, municipality, tribal government. This is a forecast: it is not yet open for applications, and the estimated deadline is 2027-03-04. Check eligibility and apply with FindGrants.
Not quite the right fit?
Search 800+ open grants, or get matches ranked for your organization — free.
Focus Areas
Eligibility
- Other Eligible ApplicantsIndian/Native American Tribal Governments (Other than Federally Recognized);Eligible Agencies of the Federal Government;U.S. Territory or Possession;Faith-based or Community-based Organizations;Regional Organizations;Non-domestic (non-U.S.) Entities (Foreign Institutions).
How to Apply
$300K–$600K
Estimated 2027-03-04
- 1Confirm your organization is eligible for Exploratory Clinical Trial Grants in Arthritis and Musculoskeletal and Skin Diseases from National Institutes of Health, checking organization type, location, and any population or project requirements.
- 2Gather the required documents and information, including your organization details, project plan, and budget figures.
- 3Draft your application narrative and budget addressing the funder's priorities and review criteria. FindGrants can draft each section for you to review and edit.
- 4Review every section against the requirements checklist, then export a submission-ready application pack and submit it to National Institutes of Health before the deadline.
Search & build free — $99 one-time to unlock the export-ready application pack. No subscription.
Don't want to draft it yourself?
We'll draft the complete application against National Institutes of Health's requirements, run a quality review, and email you a submission-ready PDF plus an editable Word doc within 5 business days. Most orders deliver in 24-48 hours. Flat $399, any grant size.
AI Requirement Analysis
Detailed requirements not yet analyzed
Have the NOFO? Paste it below for AI-powered requirement analysis.
Exploratory Clinical Trial Grants in Arthritis and Musculoskeletal and Skin Diseases: Frequently Asked Questions
Who is eligible for the Exploratory Clinical Trial Grants in Arthritis and Musculoskeletal and Skin Diseases?
Exploratory Clinical Trial Grants in Arthritis and Musculoskeletal and Skin Diseases is offered by National Institutes of Health. The listing names these applicant types: small business, municipality, tribal government, university, nonprofit, school district. It is open to organizations nationwide unless the funder specifies otherwise. The funder's eligibility section is the authority, so confirm your organization type, location, and the population or project served against it before applying.
How much funding does the Exploratory Clinical Trial Grants in Arthritis and Musculoskeletal and Skin Diseases provide?
Exploratory Clinical Trial Grants in Arthritis and Musculoskeletal and Skin Diseases provides between $300K and $600K per award from National Institutes of Health. Actual award sizes depend on the scope of your project, available program funds, and the number of applicants, so build a budget that reflects realistic, allowable costs rather than the maximum figure.
When is the Exploratory Clinical Trial Grants in Arthritis and Musculoskeletal and Skin Diseases deadline?
Exploratory Clinical Trial Grants in Arthritis and Musculoskeletal and Skin Diseases is a forecast from National Institutes of Health: it is not yet open for applications. The funder's estimated deadline is 2027-03-04, and forecast dates often change. Confirm the official posting with the funder before you prepare an application.
How do you apply for the Exploratory Clinical Trial Grants in Arthritis and Musculoskeletal and Skin Diseases?
To apply for Exploratory Clinical Trial Grants in Arthritis and Musculoskeletal and Skin Diseases, confirm your eligibility, gather the required documents, and prepare a narrative and budget that address the funder's priorities. FindGrants guides you step by step and can draft each section, then exports a submission-ready application pack for this grant from National Institutes of Health.
Browse More Grants
Related Grants
State Veterans Home Construction Grant Program
Construction of State Home Facilities — up to $275M
Advancing Global Health
Bureau of Global Health Security and Diplomacy — up to $250M
Title X Family Planning Services Grants
Office of the Assistant Secretary for Health — up to $22M
Fiscal Year (FY) 2027 Service Area Competition (SAC)
Health Resources and Services Administration — up to $10.1M
Occupational Safety and Health Education and Research Centers (T42)
Centers for Disease Control and Prevention - ERA — up to $9M
BRAIN Initiative: Integrative Team-Research BRAIN Circuits Program - iBCP (RM1 Clinical Trial Not Allowed)
National Institutes of Health — up to $8M